Global BulletinAll NewsFDA Approval AlertWomen in Oncology
Expert InterviewsAround the PracticeBetween the LinesFace OffFrom All AnglesMeeting of the MindsOncViewPodcastsTraining AcademyTreatment Algorithms with the Oncology Brothers
Conferences
All JournalsEditorial BoardFor AuthorsYear in Review
Frontline ForumSatellite Sessions
CME/CE
Awareness MonthInteractive ToolsNurse Practitioners/Physician's AssistantsPartnersSponsoredSponsored Media
Career CenterSubscribe
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
Spotlight -
  • Radiation Oncology
  • Surgery
Adverse Effects
Brain Cancer
Breast CancerBreast CancerBreast Cancer
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancersGynecologic CancersGynecologic CancersGynecologic Cancers
Head & Neck Cancer
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
InfectionInfection
Leukemia
Lung CancerLung CancerLung Cancer
Lymphoma
Neuroendocrine Tumors
Oncology
Pediatric Cancers
Radiation Oncology
Sarcoma
Screening
Skin Cancer & Melanoma
Surgery
Thyroid Cancer
    • Conferences
    • CME/CE
    • Career Center
    • Subscribe
Advertisement

Treatment Options for Early-Stage HER2-Positive Breast Cancer

home / oncview / treatment-options-for-early-stage-her2-breast-cancer

Virginia Kaklamani, MD, DSc, provides a discussion on the frontline and maintenance therapies available for the management of early-stage HER2+ breast cancer.

Advertisement

Goals of Care for HER2+ Breast Cancer

EP. 1: Goals of Care for HER2+ Breast Cancer

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor
February 1st 2022

Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.


HER2+ Breast Cancer: Frontline Treatment Options

EP. 2: HER2+ Breast Cancer: Frontline Treatment Options

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor
February 1st 2022

A review of the currently available frontline treatment options for HER2+ breast cancer.


Clinical Trial Data in HER2+ Breast Cancer

EP. 3: Clinical Trial Data in HER2+ Breast Cancer

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor
February 8th 2022

Virginia Kaklamani, MD, DSc, provides an overview of the goals of care for HER2+ breast cancer.


HER2+ Breast Cancer and the Role of Maintenance Therapies

EP. 4: HER2+ Breast Cancer and the Role of Maintenance Therapies

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor
February 8th 2022

Dr. Virginia Kaklamani discusses the role of maintenance therapies for HER2+ breast cancer.


HER2+ Breast Cancer Clinical Pearls

EP. 5: HER2+ Breast Cancer Clinical Pearls

Virginia Kaklamani, MD, DSc;Matthew Fowler, Associate Editor
February 15th 2022

Advice for community physicians treating HER2+ breast cancer.

Advertisement
About
Advertise
CureToday.com
OncLive.com
OncNursingNews.com
TargetedOnc.com
Editorial
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.